Budget impact analysis of cervical cancer screening in Portugal: comparison of cytology and primary HPV screening strategies

BMC Public Health
Angela PistaJari Kempers

Abstract

Primary Human Papilloma Virus (HPV) testing is the currently recommended cervical cancer (CxCa) screening strategy by the Portuguese Society of Gynecology (SPG) clinical consensus. However, primary HPV testing has not yet been adopted by the Portuguese organized screening programs. This modelling study compares clinical benefits and costs of replacing the current practice, namely cytology with ASCUS HPV triage, with 2 comparative strategies: 1) HPV (pooled) test with cytology triage, or 2) HPV test with 16/18 genotyping and cytology triage, in organized CxCa screenings in Portugal. A budget impact model compares screening performance, clinical outcomes and budget impact of the 3 screening strategies. A hypothetical cohort of 2,078,039 Portuguese women aged 25-64 years old women is followed for two screening cycles. Screening intervals are 3 years for cytology and 5 years for the HPV strategies. Model inputs include epidemiological, test performance and medical cost data. Clinical impacts are assessed with the numbers of CIN2-3 and CxCa detected. Annual costs, budget impact and cost of detecting one CIN2+ were calculated from a public healthcare payer's perspective. HPV testing with HPV16/18 genotyping and cytology triage (compa...Continue Reading

References

Feb 26, 1999·Journal of the National Cancer Institute·P HolowatyT To
Apr 1, 2004·International Journal of Cancer. Journal International Du Cancer·Nicole W J BulkmansChris J L M Meijer
Apr 6, 2006·International Journal of Cancer. Journal International Du Cancer·Jack CuzickThomas Iftner
Mar 8, 2007·British Journal of Cancer·N W J BulkmansUNKNOWN POBASCAM Study Group
Jul 14, 2007·Infectious Agents and Cancer·Ralph P InsingaEliav Barr
Jul 2, 2009·International Journal of Cancer. Journal International Du Cancer·Philip E CastleMark Schiffman
Nov 7, 2009·Health Technology Assessment : HTA·H C KitchenerUNKNOWN ARTISTIC Trial Study Group
Jan 22, 2010·The Lancet Oncology·Guglielmo RoncoUNKNOWN New Technologies for Cervical Cancer screening (NTCC) Working Group
Jul 16, 2010·Cancer Science·Koji MatsumotoUNKNOWN Japan HPV And Cervical Cancer (JHACC) Study Group
Jul 28, 2011·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Angela PistaUNKNOWN CLEOPATRE Portugal Study Group
Sep 29, 2011·American Journal of Obstetrics and Gynecology·Thomas C WrightTeresa L Wright
Jul 19, 2012·International Journal of Cancer. Journal International Du Cancer·Jack CuzickCatherine M Behrens
Feb 9, 2013·International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society·Angela PistaUNKNOWN CLEOPATRE Portugal Study Groupa
Jun 5, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Maaike G DijkstraJohannes Berkhof
Oct 15, 2013·International Journal of Cancer. Journal International Du Cancer·Thomas C WrightRaymond Apple
Feb 4, 2014·Journal of Medical Screening·Annarosa Del MistroUNKNOWN Veneto HPV-screening Working Group
May 6, 2015·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M ArbynM Poljak
Aug 1, 2015·Cancer Cytopathology·Lyndsay Ann RichardsonUNKNOWN PEACHS (Pap Efficacy After Cervical HPV Status) Study Consortium
Nov 5, 2015·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·A SkroumpelosJ Kyriopoulos
Jan 14, 2017·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Wiebren A A TjalmaKatleen Vandeweyer
Apr 1, 2017·European Journal of Obstetrics, Gynecology, and Reproductive Biology·Karl Ulrich PetryAnja Neumann
Sep 10, 2017·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Grazyna A StanczukMarc Arbyn

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
biopsies

Software Mentioned

FOCAL
HECON
PavDag
POBASCAM
COMPASS
Excel Office 365®
ATHENA
CLEOPATRE

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The American Journal of Managed Care
Thomas C WrightJ Thomas Cox
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Mark H EinsteinStephen P Day
© 2022 Meta ULC. All rights reserved